BBNX vs KLAC · rev $100.3M vs P/E 55, rev $13.58B
Beta Bionics, Inc. Common Stock (BBNX) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
BBNX currently screens at market cap $640.8M. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the BBNX and KLAC stock pages for the full models.
Not investment advice.